Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

KAYA LTD.

NSE : KAYABSE : 539276ISIN CODE : INE587G01015Industry : Hospital & Healthcare ServicesHouse : Marico

BSE240.90-0.9 (-0.37 %)

PREV CLOSE ( ) 241.80

OPEN PRICE ( ) 240.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4382

TODAY'S LOW / HIGH ( )234.00 248.30

52 WK LOW / HIGH ( )213.5 702.25

NSE240.75-0.15 (-0.06 %)

PREV CLOSE( ) 240.90

OPEN PRICE ( ) 232.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 21834

TODAY'S LOW / HIGH( ) 232.40 251.00

52 WK LOW / HIGH ( )204.43 699.45

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2003

Management Info

Harsh Mariwala - Chairman Harsh Mariwala - Managing Director

Registered Office

Address Marks, 23/ C, Mahal Industrial Estate, Mahakali Caves Road,Near Paperbox Lane,Andheri (East),
Mumbai,
Maharashtra-400093

Phone 022 - 66195000

Email investorrelations@kayaindia.net

Website www.kaya.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

29Jan Kaya informs about integrated filing
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..

20Jan Kaya informs about conference call
Kaya has informed that the Company will hold an investor/analyst confere..

17Jan Kaya informs about board meeting
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

13Jan Kaya informs about compliances-certifi
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants)..

16Oct Kaya informs about board meeting
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	-153.98	-1387.18
Gross Profit	-153.98	-1387.18
Operating Profit	20.62	-775.8
Net Sales	583.51	2103.25

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 4000.85 (1.05%)	M.Cap ( in Cr)1880.40
Thyrocare Tech. (BSE) 939.65 (3.53%)	M.Cap ( in Cr)4979.53
Max Healthcare Inst (BSE) 1126.95 (1.50%)	M.Cap ( in Cr)109555.55
Metropolis Health. (BSE) 1667.15 (0.39%)	M.Cap ( in Cr)8549.64
RainbowChildrenS Med (BSE) 1346.45 (0.47%)	M.Cap ( in Cr)13673.43

Shareholding Pattern

	PROMOTERS	59.64%
	NON-INSTITUTION	37.16%
	FI/BANKS/INSURANCE	0%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

KAYA LTD.